Effects of Long-Term Treatment with Fluvoxamine on Non-Motor Symptoms and Neurogenesis in an Early Post-Natal Stress Rat Model of Parkinson’s Disease
Objective: To look at the long-term effects of Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), and its neuroprotection potential in a rat model of Parkinson’s…PRO-PARK study: Is there an association between PROfessional occupation and PARKinson´s disease?
Objective: To asses if there is an association between professional occupation and Parkinson´s disease (PD). Background: Some personality features including rigidity, less novelty-seeking, and less…Quality of Life in Parkinson´s Disease Patients with Depression and Impulsive-compulsive Behaviors
Objective: To analyze quality of life (QoL) in Parkinson´s disease (PD) patients regarding to have depression, impulsive-compulsive behaviors (ICBs), or both. Background: Depression and ICBs are…Long-term effects of air pollution on the risk of Parkinson’s disease
Objective: We aimed to investigate the association between air pollution, including fine particulate matter (particles 2.5 mm in diameter, or PM2.5), and the risk of…Psychiatric comorbidities in Young Onset Parkinson’s disease
Objective: The study aims at exploring psychiatric comorbities;namely;anxiety,depression and impulse control disorders(ICD) and their inter relationship in a large cohort of Young onset PD(YOPD)patients. Background:…Safety and efficacy of istradefylline, an adenosine A2A receptor antagonist, as a function of baseline dyskinesia (BL-dyskinesia) in Parkinson’s disease (PD): A pooled analysis of 4 studies
Objective: To evaluate the effect of BL-dyskinesia on the efficacy and safety of istradefylline in 4 randomized, placebo-controlled, double-blind, phase 2b/3 trials. Background: Istradefylline, a…Interpretation of health-related quality of life outcomes from the EARLYSTIM Study
Objective: To conduct a secondary analysis of the EARLYSTIM study1 to 1: Quantify the meaning of HRQoL outcomes and 2: Evaluate the changes of disease…Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Effect on MDS-UPDRS Part III Subdomains
Objective: Evaluate effect of apomorphine sublingual film (APL-130277; APL) as an on-demand treatment of “OFF” episodes in patients with Parkinson’s disease (PD) on MDS-UPDRS Part…Can we customize tune for asymmetric tremor with differentiated Deep brain stimulation frequencies?
Objective: We aimed to display if differentiated frequency can improve the tremor in patients with STN-DBS. Background: Subthalamic deep brain stimulation (STN-DBS) is the best…The Indian Experience of Continuous Dopaminergic therapy with Apomorphine in Parkinson’s Disease
Objective: A clinical audit of apomorphine pumps – The Indian experience. Background: Continuous dopaminergic therapy remains crucial in the management of moderately advanced Parkinson’s disease…
- « Previous Page
- 1
- …
- 73
- 74
- 75
- 76
- 77
- …
- 388
- Next Page »